NCT04119908 Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
| NCT ID | NCT04119908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Lille |
| Condition | Von Willebrand Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2023-05-24 |
| Primary Completion | 2028-05-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2023-05-24 with a primary completion date of 2028-05-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In Willebrand disease, there is currently no test available to identify non-invasively patients with a high risk of bleeding from angiodysplasias The study propose to use a sublingual capillary bed analysis by video-microscopy, a sensitive, reproducible and non-invasive technique, to assess whether sublingual capillary density is predictive of hemorrhagic risk for patients with von Willebrand disease.
Eligibility Criteria
Inclusion Criteria: * Adult patient with a significant form of von Willebrand disease (according to the inclusion criteria of the Willebrand Disease French Reference Center), a Glanzmann Thrombasthenia, a moderate to severe Haemophilia A or a woman carrying the hemophilia gene * Social insured patient Exclusion Criteria: * Minor patient * Refusal of consent * Person benefiting from a system of legal protection * Pregnant patient
Contact & Investigator
Antoine Rauch, MD,PhD
PRINCIPAL INVESTIGATOR
University Hospital, Lille
Frequently Asked Questions
Who can join the NCT04119908 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Von Willebrand Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04119908 currently recruiting?
Yes, NCT04119908 is actively recruiting participants. Contact the research team at antoine.rauch@chru-lille.fr for enrollment information.
Where is the NCT04119908 trial being conducted?
This trial is being conducted at Lille, France.
Who is sponsoring the NCT04119908 clinical trial?
NCT04119908 is sponsored by University Hospital, Lille. The principal investigator is Antoine Rauch, MD,PhD at University Hospital, Lille. The trial plans to enroll 400 participants.